Found 8 matching trials
BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression
PHASE2This is a multicenter, single-arm, phase II clinical study evaluating the e...
Status
Enrolling By Invitation
Location
The First People's Hospital of Foshan
SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma
PHASE2The purpose of the study is to assess the safety and effectiveness of SCT-I...
Location
307 Hospital of PLA
SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
PHASE3The objective of this study is to evaluate the efficacy and safety of SCT-I...
Location
The Third Affiliated Hospital Of Qiqihar Medical University
SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
PHASE1The study is to explore the efficacy and safety of SCT200 with SCT-I10A or ...
Location
Shanghai East Hospital
SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung Cancer
PHASE3This is a phase 3 double-blinded randomized multicenter clinical trial of S...
Location
Shanghai Chest Hospital
Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC
PHASE1The purpose of this study is to evaluate the safety and efficacy of SCT-I10...
Location
Multiple Locations
Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma
PHASE1The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Location
The Fifth Medical Center of PLA General Hospital
Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma
PHASE2The objective of this study is to evaluate the efficacy and safety of SCT-I...
Location
Guangxi Medical University Affiliated Tumour Hospital